Related Experiment Video
Updated: Jul 19, 2026
Non-contact, Label-free Monitoring of Cells and Extracellular Matrix using Raman Spectroscopy
Published on: May 29, 2012
Detection of free elastin-derived peptides among diabetic children
G Nicoloff1, Ch Petrova, P Christova
1Department of Biology & Pathological Physiology, Medical University, Pleven, Bulgaria. nicoloff_bg@yahoo.com <nicoloff_bg@yahoo.com>
Insights
Elevated elastin-derived peptides (EDP) in children with Type 1 diabetes correlate with microvascular complications. Higher free EDP levels are linked to conditions like microalbuminuria and retinopathy, indicating a potential biomarker for disease progression.
Area of Science:
- Biochemistry
- Endocrinology
- Pediatrics
Background:
- Elastin breakdown products, known as elastin-derived peptides (EDP), are present in human serum.
- Circulating immune complexes (CIC) can form from EDP and antibodies, potentially influencing disease processes.
Purpose of the Study:
- To investigate the correlation between serum levels of free EDP (unbound in CIC) and the development of microvascular complications in children with Type 1 diabetes mellitus.
- To assess if free EDP serves as a biomarker for diabetic vascular complications in pediatric patients.
Main Methods:
- Utilized a combination of immune complex detection (CIF-ELISA) and EDP detection (ELISA) assays.
- Analyzed serum samples from 81 children with Type 1 diabetes (42 with vascular complications, 39 without) and 21 healthy controls.
Main Results:
- Diabetic children exhibited significantly higher free EDP levels compared to healthy controls (p=0.003).
- Children with vascular complications showed markedly elevated free EDP levels versus controls (p=0.0001).
- Free EDP levels correlated with insulin dose, microalbuminuria, retinopathy, HbA1c, systolic blood pressure, and total cholesterol in diabetic patients with vascular pathology.
Conclusions:
- Elevated serum levels of free elastin-derived peptides are associated with the development of diabetic vascular complications in children.
- Free EDP may represent a significant biomarker for predicting and monitoring microvascular disease progression in pediatric Type 1 diabetes.
Abstract:
Elastin breakdown products are found in the serum of all human subjects. The presence of these elastin-derived peptides (EDP) and the corresponding antibodies in circulation leads to formation of circulating immune complexes (CIC). The aim of this study was to determine if serum level of free-EDP (unbound in CIC) correlate with the development of microvascular complications in children with Type 1 (insulin-dependent) diabetes mellitus. To this end we used a method for detecting immune complexes (CIF-ELISA) in combination with an ELISA for detection of EDP. The levels of free EDP were studied in sera of 81 diabetic children (mean age 13.46+/-3.51 years, diabetes duration 5.17+/-4.21 years). Forty-two of the children had vascular complications (group 1) and 39 were without vascular complications (group 2). Twenty-one healthy children (mean age 12.6+/-2.47 years) were used as controls. Diabetics showed significantly higher levels of free EDP (68.1+/-25 ng/ml versus 51+/-12.5 ng/ml; p=0.003) compared to the control group. In group 1, free EDP showed significantly higher levels than controls (78.9+/-25.6 ng/ml versus 51+/-12.5 ng/ml; p=0.0001). About 38 of 81 (47%) patients were positive for free EDP (30/42--71% in group 1 and 8/39--21% in group 2). Free EDP levels in all diabetics showed a correlation with insulin dose (r=0.23; p=0.041), and microalbuminuria (r=0.57; p=0.0001). Patients who had vascular pathology showed a correlation of free EDP with microalbuminuria (r=0.41; p=0.0081), retinopathy (r=0.32; p=0.041), insulin dose (r=0.37; p=0.02), HbA1c (r=0.35; p=0.03), systolic blood pressure (r=0.30; p=0.045) and total cholesterol (r=0.36; p=0.02). These findings suggest that elevated levels of free EDP are associated with the development of diabetic vascular complications in children.
